A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$42.56
0.00%
(0.00) 1D
Nov 10, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1LN34...
Open
R$43.88
High
R$43.88
Low
R$42.25
Mkt. cap
20.31B
Avg. vol.
4.81K
Volume
257.00
52-wk high
R$126.48
52-wk low
R$42.25
Shares outstanding
133.94M
No. of employees
2K
Open
R$43.88
High
R$43.88
Low
R$42.25
Mkt. cap
20.31B
Avg. vol.
4.81K
Volume
257.00
52-wk high
R$126.48
52-wk low
R$42.25
Shares outstanding
133.94M
No. of employees
2K
News stories
From web sources and news partners
富途牛牛
·
11 minutes ago
Review & Preview: Hot Inflation -- Barrons.com
ChartMill
·
1 hour ago
QumulusAI (NASDAQ:QMLS) Q3 Revenue Beats Estimates but Shares Fall on Operating Losses
Mott Capital Management
·
1 hour ago
The S&P 500 Has A Nvidia Problem
Yahoo Finance
·
2 hours ago
Why this top Wall Street strategist isn't bullish on the S&P 500 for 2027
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr
CEO-
Employees2.5K
FoundedJun 14, 2002
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitealnylam.com